Investorideas.com

Investorideas.com
Breaking News

Tuesday, October 10, 2017

#Cannabis News: (OTC: $SVSN) Subsidiary CannaVision Announces Plans to Open Three Medical Cannabis and Holistic Pain Management Clinics in the Tampa Bay Metropolitan Area

#Cannabis News: (OTC: $SVSN) Subsidiary CannaVision Announces Plans to Open Three Medical Cannabis and Holistic Pain Management Clinics in the Tampa Bay Metropolitan Area



LAS VEGAS, NEVADA - October 10, 2017 (Investorideas.com Newswire) StereoVision Entertainment, Inc. (OTC PINK: SVSN), a publicly traded Nevada corporation announced today that their majority owned medical cannabis clinic and industrial hemp subsidiary CannaVision plans to open three medical cannabis and holistic pain management clinics in the Tampa Bay metropolitan area.

Read this news in full at

“We’re seeing high demand for medical cannabis cards in Florida,” stated CannaVision President Marla Marloch. “We believe John Morgan, who has 100% support from CannaVision’s management and investors, will prevail in his efforts to allow the medical use of the whole marijuana plant by qualified medical marijuana patients in Florida. A victory for his lawsuit representing the freedom of choice for Florida’s qualified medical marijuana patients is expected to generate exponible growth in the number of people seeking qualification for medical marijuana cards. With this investment in Tampa Bay’s metropolitan area we’re continuing to grow our CannaVision Clinics footprint throughout the state.”

StereoVision Entertainment Inc. http://stereovision.com Headquartered in Las Vegas, Nevada StereoVision is a publicly traded Nevada corporation (OTC:SVSN) focused on creating, acquiring, and producing multimedia content with its media subsidiaries, the wholly owned 9 time Emmy Award - winning production company REZN8, http://rezn8.com, the majority - owned family entertainment company, Inspirational Vision Media, http://ivmi.biz and the majority - owned Florida medical marijuana clinic and industrial hemp corporation MediCannaVision Inc., dba CannaVision. http://cannavisionclinics.com

Safe Harbor Statement: Except for historical information certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and those statements are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company cautions that these forward-looking statements are qualified by other factors. The Company undertakes no obligation to publicly update any statements in this release.

Contact: Jack Honour 818-326-6018 info@stereovision.com

Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info:
Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory



Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video

Scythian Biosciences Corp.’s (TSXV: $SCYB.V) Professional Athlete Advisory Committee Head, NFL Star Bart Oates says, “Company has a winning team”

  

Scythian Biosciences Corp.’s (TSXV: $SCYB.V) Professional Athlete Advisory Committee Head, NFL Star Bart Oates says, “Company has a winning team”




October 10, 2017 – Investorideas.com, a global news source and investor resource covering cannabis and biotech stocks issues an exclusive podcast interview with NFL Champion Bart Oates, the first appointment of  the Scythian Biosciences  (TSX.V: SCYB) Professional Athlete Advisory Committee.

Oates, a five-time NFL Pro Bowl player and three-time Super Bowl Champion, was announced as the first appointee to the newly formed committee on October 2. Oates identified the strength of the team in all areas as a guide to why Scythian will be successful.

He also shares his personal experiences with concussions in the NFL and his education of the company’s treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination and how it can make a difference going forward.


Hear the full podcast: 

About Mr. Oates

A former center for the New York Giants and San Francisco 49ers, Bart Oates is a 5-time NFL Pro Bowl player and a 3-time Super Bowl Champion. Once finished with football, Mr. Oates took law classes and then worked as an attorney, receiving his law degree from Seton Hall University. Mr. Oates maintains an active role in many services to the community, including serving as President of the NY/NJ Chapter of the NFL Alumni Association.

Scythian ( http://scythianbio.com/)  is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination. 

Scythian's mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen.  The University of Miami believes that Scythian's scientific approach shows significant promise and differs from previous approaches to treat this growing problem.  The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythian's clinical studies to be undertaken at their world-class facilities.   

Gillian A. Hotz, PhD, is leading Scythian's program at the University of Miami.  Dr. Hotz is a nationally recognized behavioral neuroscientist and expert in neurotrauma, concussion management, and neurorehabilitation.  She has extensive experience in neurocognitive testing.  Dr. Hotz has been the co-director of University of Miami Miller School of Medicine's Concussion Program since 1995. 

Scythian is also endorsed by Pro Football Legends and the World Boxing Association on its mission.


About Investorideas.com - News that Inspires Big Ideas
www.Investorideas.com  is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

The Investorideas.com podcasts are also available on iTunes, Tunein, Stitcher. Spreaker.com, iHeart.com Radio  and Google Play Music.
Visit the Podcast page at Investorideas.com: http://www.investorideas.com/Audio/

Subscribe to Investorideas.com Podcast RSS:

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp


Contact Investorideas.com
800-665-0411